Better Therapeutics, Inc.
BTTX
Revenue
8.00k
▲8.00k∞%
-Assets
10.72M
▼-882.00k▼-7.60%
3 Months ChangeLiabilities
20.66M
▼-1.73M▼-7.74%
3 Months ChangeFree Cash Flow
-13.83M
▼-4.93M▼-55.45%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-03-21
Form 8-K
ID: 0001193125-24-073819
2024-03-15
Form 8-K
ID: 0001193125-24-068672
2024-03-14
Form 8-K
ID: 0001193125-24-067483
2024-03-11
Form 8-K
ID: 0001193125-24-064404
2024-03-04
Form 8-K
ID: 0001193125-24-056981
2024-01-08
Form 8-K
ID: 0001193125-24-004495
2023-12-18
Form 8-K
ID: 0001193125-23-296870
2023-12-13
Form 8-K
ID: 0001193125-23-294438
2023-11-30
Form 8-K
ID: 0001193125-23-286277
2023-11-20
Form 8-K
ID: 0000950170-23-065185